MedTrace Logo

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

NCT00994734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 615

Last updated 2012-04-17

No results posted yet for this study

Summary

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Conditions

  • Termination of Pregnancy

Interventions

DRUG

Mifepristone

home administration of mifepristone

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States
  • Moldova
  • Nepal

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00994734 on ClinicalTrials.gov